June 4（NBD）- Northeast Pharmaceutical Group Co., Ltd (Northeast Pharma, 000597.SZ) released a filing Sunday that its second largest shareholder Liaoning Fangda Group Industrial Co Ltd (Fangda Group) bought 28.4962 million shares (5 percent of total capital stock) through auction trading from May 28 to June 1.

After the deal, Fangda Group holds a total of 104 million shares in Northeast Pharma, a 18.20 percent of the latter's capital stock. It is noted that Fangda Group is the controlling shareholder of Fangda Carbon New Material Technology Co., Ltd. (Fangda Carbon, 600516.SH), and the company doesn't rule out the possibility of raising its stake further in Northeast Pharma in the next 12 months. 

Email: tanyuhan@nbd.com.cn